Ardent Health Partners, LLC
ARDT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $1 | $2 |
| % Growth | -4.2% | 9.9% | -6.8% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $1 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 57.1% | 83.6% | 82.7% | 59.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 16.1% | 8.3% | 4.5% | 21% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$0 | $0 | $0 | $0 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -1.5% | 4.4% | 2.8% | 7.1% |
| EPS | -0.17 | 0.52 | 0.3 | 0.8 |
| % Growth | -132.7% | 73.3% | -62.5% | – |
| EPS Diluted | -0.17 | 0.52 | 0.29 | 0.86 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 3.5% | 10.7% | 8.3% | 12.2% |